Michelle Rosenthal BPharm, MPS

Michelle is a registered pharmacist and since 2007 has been the Branch Director of the Queensland Branch of the Pharmaceutical Society of Australia (PSA) and has held senior management roles across a variety of organisations. A graduate of the University of Queensland, Michelle’s career has spanned hospital and community practice and the pharmaceutical industry. Her early career was in hospital pharmacy where she developed her interests in clinical pharmacy in the areas of infectious diseases, oncology and psychiatry. She spent over 12 years in the pharmaceutical industry where she held a variety of roles in sales and marketing, most notably in the new product development of CNS pipeline products with Eli Lilly including Olanzapine (Zyprexa).